Antonio Costanzo

Full Professor of Dermatology

Humanitas University

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Antonio Costanzo is a Full Professor of Dermatology at Humanitas University in Italy. His research focuses on the treatment and management of various dermatological conditions, with recent articles addressing topics such as the response of psoriasis to different treatments, effectiveness of novel therapies for atopic dermatitis, and the impact of age on disease onset. He is actively involved in multi-center studies and clinical practice guidelines related to skin diseases.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Andreas Pinter

University Hospital Frankfurt

GERMANY

View details

Richard Weller

Reader

University of Edinburgh

UNITED KINGDOM

View details

Riccardo Borroni

Associate Professor of Dermatology and Venereology

Humanitas University

ITALY

View details

Mar Llamas‐Velasco

SPAIN

View details

stefano piaserico

Associate Professor

University of Padua

ITALY

View details

Paolo Gisondi

University of Verona

ITALY

View details

Andrea Carugno

Adjunct Professor

University of Milano-Bicocca

ITALY

View details

jose-manuel carrascosa

head of department, associated professor

Hospital Universitari Germans Trias i Pujol

SPAIN

View details

Piergiorgio Malagoli

CHIEF

IRCCS Ospedale San Raffaele

ITALY

View details

Lars Iversen

Aarhus University

DENMARK

View details

Albert Chiou

Clinical Assistant Professor

Stanford University School of Medicine

UNITED STATES

View details

Stefania Guida

Vita-Salute San Raffaele University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonio Costanzo

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Reply to Hagino et al.: ‘Importance of Upadacitinib dose escalation prior to switch to lebrikizumab’

Age of onset matters: tildrakizumab response in early- vs. late-onset psoriasis

What is ‘ chronic ’ pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatment

Clearance of Darier disease lesions in a patient with concomitant atopic dermatitis treated with abrocitinib

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study

Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study

Italian Expert Opinion on Chronic Hand Eczema: from Guidelines to Clinical Practice

Arrhythmias and other cardiovascular diseases in young patients (<40 years) with moderate/severe atopic dermatitis: A multicentric study in northern Italy

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate‐to‐severe plaque psoriasis patients in conditions close to clinical practice

Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study

Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study

Cutaneous toxicity of CAR T‐cell therapy: Case report of a bullous life‐threatening reaction

Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)

Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab

Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)

Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)

Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID‐19 vaccine, successfully treated with risankizumab

A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

Collaborators (12)

Andreas Pinter

Richard Weller

Riccardo Borroni

Mar Llamas‐Velasco

stefano piaserico

Paolo Gisondi

Andrea Carugno

jose-manuel carrascosa

Piergiorgio Malagoli

Lars Iversen

Albert Chiou

Stefania Guida

Make your next move.